Indonesia has officially entered the race to become Asia's next major medical tourism destination, and it is not subtle about what it wants. As Bali bets on integrated wellness-and-clinical tourism, China is pursuing its own path under the 2026 nine-ministry medical visa framework.
The Sanur Health Special Economic Zone, a 41-hectare integrated health and wellness precinct in Bali, opened its flagship Bali International Hospital in June 2025. By April 2026, the zone had already attracted over 60,000 international and domestic patients in its first operational year, according to project data published by the Indonesian Ministry of Tourism. The development, led by state-owned hospitality group PT Hotel Indonesia Natour, is targeting 140,000 patients annually by 2027, with a deliberate strategy to pull Indonesian medical travellers away from Bangkok and Singapore, and to position Bali as a credible competitor for regional medical tourists from Australia, Japan, and the Middle East.
The model is different. Rather than building a standalone hospital and hoping patients arrive, Sanur weaves medical services into a resort and wellness ecosystem: hospitals alongside rehabilitation centres, spa facilities, fitness programs, and traditional wellness retreats. The idea is that recovery is not a clinical endpoint but an experience. Bali's global reputation as a wellness destination is the foundation the project builds on.
For China, which has been quietly expanding its own international patient programmes under the nine-ministry medical visa framework introduced in 2026, this is a new competitive signal. Beijing has not been standing still. But neither has the market moved in China's favour.
Indonesia's Sanur Medical Zone is not a government pitch deck anymore. It is operating, treating patients, and building a track record. The project is the most concrete statement Indonesia has made about its ambitions in the health tourism sector, and it comes at a time when several established Asian medical tourism markets are tightening entry requirements or restructuring their regulatory frameworks.
Thailand, which has dominated the sector for decades, introduced mandatory health insurance for inbound tourists starting in 2026. Malaysia has doubled down on its Malaysia Healthcare Travel brand. Singapore continues to hold the premium tier, attracting high-complexity cases. Into this landscape, Indonesia arrives with a different value proposition: the combination of clinical care, holistic recovery, and lifestyle tourism that no single city in the region has yet fully delivered.
What makes Sanur notable beyond the headline numbers is its integrated model. Patients arriving for surgery can access post-operative care, physiotherapy, nutritional programming, and stress-reduction therapies in a single location, backed by internationally recruited medical staff and partnerships with overseas hospital networks. The zone has signed accreditation agreements with several international healthcare standards bodies, and its targeted patient mix includes oncology, orthopaedics, cardiovascular screening, and executive health checks.
This is a direct challenge to the way medical tourism has traditionally worked in Asia, which centres on a hospital, a hotel nearby, and a recovery period spent waiting rather than actively rehabilitating.
China's approach to international patients has been methodical but less visible. Under the 2026 nine-ministry policy framework, foreign patients can now obtain medical visas backed by sponsor hospital documentation, with faster processing times and simplified admission procedures at designated international hospitals in Beijing, Shanghai, Guangzhou, Hangzhou, and Chengdu.
These hospitals, many of which have JCI accreditation or equivalent international certifications, have invested significantly in dedicated international patient centres, English-speaking staff, and specialist programmes for overseas visitors. The volume is real: China treated an estimated 800,000 foreign patients in 2025, according to figures from the National Health Commission, a figure that has grown steadily since the medical visa programme launched.
But China's pitch is primarily clinical. The country provides deep specialist expertise, large hospital capacity, and cost-competitive pricing for complex procedures. What it has not yet developed, at least not at scale, is the integrated wellness-and-recovery experience that destinations like Bali are now targeting.
The two markets are not directly competing for the same patients. China's medical tourists tend to seek specific treatments: advanced surgery, cancer care, fertility treatments, and diagnostic excellence. Bali's emerging patient profile leans toward combination health-and-leisure: the executive health check combined with a Bali recovery retreat, or post-surgical rehabilitation in a beachside setting.
Where they do intersect is the broader question of which destination Asia's growing class of health-focused travellers will choose when they need care that their home systems cannot easily provide.
The most interesting thing about Sanur is not the hospital; it is the ecosystem logic. By embedding recovery within a wellness environment and tying it to Bali's existing tourism infrastructure, the project is attempting something that Thailand, Malaysia, and Singapore have talked about for years but not fully delivered.
Thailand's medical tourism success has always had a hotel-adjacent quality: good hospitals, excellent hospitality, and a tourism ecosystem that makes the trip pleasant. But integration has been additive rather than architectural. Bali appears to be building from the ground up with integration as the starting principle.
Whether it can deliver clinical quality at scale is the open question. Indonesia's healthcare system has historically struggled with consistent quality outside of major cities. Sanur is explicitly trying to solve this by importing expertise: the Bali International Hospital has recruited specialists internationally and partnered with overseas academic medical centres for second opinions and clinical protocols.
For Chinese health authorities and hospital administrators, the lesson may not be "copy Bali" but "notice what Bali is attempting to do differently." The market for medical tourism is not static. It is segmenting. The next wave of patients will not simply choose the cheapest or the closest option; they will choose the experience.
| Dimension | Bali Sanur Medical Zone, Indonesia | China International Medical Tourism |
|---|---|---|
| Target Patient Volume | 140,000+ annually (by 2027) | ~800,000 foreign patients (2025) |
| Key Specialties | Oncology, orthopaedics, cardiovascular screening, executive health, wellness rehabilitation | Complex surgery, oncology, fertility, advanced diagnostics |
| Entry Requirements | Passport, proof of insurance or deposit | Medical visa (sponsor-backed, 2026 framework) |
| Insurance | Mandatory health coverage for inbound tourists under study | Hospital-level insurance verification |
| Accreditation | International healthcare standards bodies | JCI accreditation or equivalent at major international hospitals |
| Recovery Model | Integrated resort + clinical + wellness | Primarily clinical, hotel recovery nearby |
| Tourism Integration | Native: hospital, spa, rehab, resort all in one zone | Add-on: separate logistics required |
| Language Capacity | English, Mandarin, Arabic (target markets) | English at international patient centres |
| Pricing Position | Premium mid-tier | Cost-competitive across most procedures |
| Key Source Markets | Australia, Japan, Middle East, domestic Indonesia | Southeast Asia, Middle East, Africa, Central Asia |
| Regulatory Framework | Sanur Health Special Economic Zone legislation | Nine-ministry medical visa framework (2026) |
Bali's emergence does not immediately threaten China's position in medical tourism. The patient pools overlap only partially, and China's clinical depth, particularly in high-complexity cases, is not something a new zone in Bali can replicate in its first years.
But the competitive dynamics are shifting in a direction that deserves attention. The medical tourism market in Asia is no longer simply about who has the best hospitals or the lowest prices. It is increasingly about the entire patient journey, and that includes the recovery environment, the integration of wellness services, and the quality of the surrounding tourism experience.
China's nine-ministry framework is a genuine step forward. But translating policy into a differentiated patient experience that competes with what Bali is now offering will require more than faster visa processing. It will require a rethink of how international patients move through, and recover in, Chinese hospital systems.
The race is on. And for the first time in years, it is not just about who has the best surgeons.
China's top international hospitals offer world-class facilities, JCI-accredited care, and streamlined medical visa support. Get a free consultation to understand your options.
Get a Free Consultation